Ignacio Matos

6PUBLICATIONS

67CO-AUTHORS

Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 13, 2026

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Dec 07, 2023

Fcγ receptors and immunomodulatory antibodies in cancer.

Felipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya

|Sep 01, 2023

Druggable Targets in Cytokine Release Syndromes.

Carlos Luri-Rey, Iñaki Eguren-Santamaria, Ignacio Matos

|Mar 11, 2023

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.

Lee X Li, Federico Cappuzzo, Ignacio Matos

|Feb 07, 2023

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero

|Jan 26, 2021

A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.

Marta Ligero, Alonso Garcia-Ruiz, Cristina Viaplana

Pageof 1

Frequent Collaborators

Maria Ochoa-de-Olza

Eva Muñoz-Couselo

Elena Garralda

Marta Ligero

Alonso Garcia-Ruiz

Cristina Viaplana

Guillermo Villacampa

Maria V Raciti

Joaquin Mateo

Rafael Morales-Barrera

Frequent Collaborators

Maria Ochoa-de-Olza

Eva Muñoz-Couselo

Elena Garralda

Marta Ligero